Ivermectin Tested against 28 types of Cancer: Most Sensitive vs Least Sensitive
A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin.
Ivermectin was also found to be synergistic with docetaxel, cyclophosphamide and tamoxifen.
Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.
Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration.
The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial.
Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma
Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias.
Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy:
“Ivermectin has a preferential depletion effect on the cancer stem-like cell population…”
“We observed that among all the evaluated cell lines, a decrease in cell viability and clonogenicity is more evident in the cancer stem-like cells than in their parental population.”
KEY findings of this study: At a human dose of 2mg/kg, Ivermectin can achieve anti-cancer effects such as cell cycle arrest (inhibit proliferation), preferrential inhibition of cancer stem-like cells, synergize with several chemotherapy drugs and inhibit tumor growth in a breast cancer mouse model.
New & Improved Joe Tippens Protocol
In 2016, Joe Tippens was diagnosed with non-small-cell lung cancer with extensive metastatic disease. At the advice of a veterinarian friend, he took Fenbendazole together with nanocurcumin, and three months after starting these drugs his PET scan was completely clear.
Below is a modified version of the Joe Tippens protocol, a synergistic combination of fenbendazole,ivermectin and nutraceuticals, as recommended by Canadian oncologist Dr. William Makis.
- Fenbendazole is commonly taken at 300 mg for six days a week, with doses increasing to up to 1 gram in cases of aggressive "turbo cancers." The original Joe Tippens protocol recommended the Panacur C brand of fenbendazole.
- Ivermectin (24 mg, 7 days a week) or in the case of severe turbo cancers up to 1mg/kg/day.
- Lifestyle: Eliminate sugar (BMJ 2023), adopt a whole-food diet, avoid ultra-processed foods (BMJ 2024), prioritize sleep, and manage stress.
- Bio-Available Curcumin (600mg per day, 7 days a week).
- Vitamin D (62.5 mcg [2500 IU] seven days a week).
- Enhanced absorption Berberine (500mg per day) if you are trying to starve your cancer of sugars.
Please note that this protocol now includes the vital Vitamin D addition, with the one day off for the fenbendazole administration. This protocol represents the most comprehensive and cutting edge repurposed drug and vitamin treatment approach to date.
*Note: If you are taking ivermectin and mebendazole, you might not need fenbendazole. Consult your doctor.
- Vitamin E: Removed from the protocol (Joe Tippens, July 22, 2020) due to interactions (e.g., with blood thinners).
Source: Adapted from OneDayMD.com. https://www.onedaymd.com/2024/11/fenbendazole-and-cancer-15-minutes-with.html (November 2024).
RELATED:
.png)
.png)
%20in%20a%20visually%20appealing%20way,%20without%20any%20text.%20The%20background%20is%20split_%20one%20side%20has%20a%20sci.webp)
.png)
Comments
Post a Comment